Page last updated: 2024-09-05

lapatinib and ly2090314

lapatinib has been researched along with ly2090314 in 1 studies

Compound Research Comparison

Studies
(lapatinib)
Trials
(lapatinib)
Recent Studies (post-2010)
(lapatinib)
Studies
(ly2090314)
Trials
(ly2090314)
Recent Studies (post-2010) (ly2090314)
1,9193051,442917

Protein Interaction Comparison

ProteinTaxonomylapatinib (IC50)ly2090314 (IC50)
Protein kinase C beta typeHomo sapiens (human)0.42
Cyclin-dependent kinase 4Homo sapiens (human)1.8
Cyclin-dependent kinase 2Homo sapiens (human)2.8
Glycogen synthase kinase-3 alphaHomo sapiens (human)0.0013
Glycogen synthase kinase-3 betaHomo sapiens (human)0.001
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)6.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB1

Other Studies

1 other study(ies) available for lapatinib and ly2090314

ArticleYear
Navigating the kinome.
    Nature chemical biology, 2011, Volume: 7, Issue:4

    Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology

2011